What is the latest Central Line-Associated Bloodstream Infection (CLABSI) guideline for preventing and managing CLABSI in patients with central lines?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 28, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Latest CRBSI/CLABSI Guideline

The most recent guideline is the 2024 International Society for Infectious Diseases (ISID) position paper on preventing central line-associated bloodstream infections, published in 2025 in the International Journal of Infectious Diseases. 1

Key Updates from the 2024 ISID Guideline

The ISID guideline represents a comprehensive update covering literature from January 2014 through June 2024, with recommendations organized into nine distinct categories to guide clinical practice. 1

Necessary Prerequisites for CLABSI Prevention Programs

Before implementing prevention strategies, healthcare facilities must establish:

  • Education and training infrastructure with dedicated resources 1
  • Infection prevention team capable of identifying patients meeting CLABSI definitions 1
  • Information technology support for tracking central line-days and patient-days to calculate device utilization ratios 1
  • Validation systems that compare automated CL-day counts to manual methods, with acceptable error margins not exceeding ±5% 1
  • Laboratory support for timely specimen processing and result reporting 1

Core Prevention Strategy: Multidimensional Approach

The guideline mandates implementing six simultaneous components:

  1. Evidence-based care bundles 1
  2. Comprehensive education programs for healthcare professionals, patients, and caregivers 1
  3. CLABSI surveillance using CDC/NHSN uniform methods and definitions 1
  4. Compliance monitoring with recommended practices 1
  5. Internal rate reporting stratified by unit type 1
  6. Performance feedback to clinical teams 1

This approach has demonstrated effectiveness across 30 countries, reducing CLABSI rates from 15.34/1,000 CL-days to 2.23/1,000 CL-days over 29 months. 1

Insertion Bundle Requirements

All healthcare providers must wear mask, cap, sterile gown, and sterile gloves, with the patient covered by a large sterile drape. 2

  • Perform hand hygiene before insertion or manipulation using alcohol-based hand rub or soap and water, regardless of glove use 2
  • Use 2% alcoholic chlorhexidine for skin antisepsis, allowing complete drying before insertion 2
  • Avoid femoral vein placement when possible, as peripherally inserted central catheters (PICCs) demonstrate the lowest CLABSI risk 1, 2
  • Apply ultrasound guidance for internal jugular and femoral vein catheterization to reduce complications 2

Maintenance Bundle Components

Review central line necessity daily and remove promptly when no longer needed. 2

  • Use transparent semipermeable dressings replaced every 7 days, or chlorhexidine-impregnated dressings for patients over two months of age 2
  • Replace dressings immediately if soiled, loose, or damp 2
  • Disinfect catheter hubs and needleless connectors before each access using alcoholic chlorhexidine or 70% alcohol with mechanical friction 2
  • Provide daily chlorhexidine bathing for ICU patients over two months of age (avoid in infants under two months due to skin injury risk) 2

Surveillance Methodology

Calculate CLABSI rates as the number of infections divided by total CL-days, multiplied by 1,000. 1

  • Stratify rates by patient-care unit type for meaningful comparisons 1
  • Monitor CL-device utilization ratios longitudinally to identify variations 1
  • Extend surveillance to all catheter types including peripheral arterial catheters, short-term peripheral venous catheters, and midline catheters 1
  • Count central line-days based on physical patient location, not service attribution 3

Education and Competency Requirements

Mandate education and competency assessments for all healthcare professionals involved in CL insertion, care, and maintenance. 1, 2

This includes understanding appropriate insertion indications, implementing prevention recommendations, and conducting daily assessments of ongoing CL necessity. 1

Practices to Avoid

  • Do not routinely replace central lines or arterial catheters 2
  • Avoid systemic antimicrobial prophylaxis during short-term tunneled catheter insertion or while catheters remain in place 2

Resource-Limited Settings Adaptations

  • Use collapsible closed-system IV fluid containers instead of open-system rigid containers 2
  • Use needleless connectors instead of three-way stopcocks, preferring positive displacement types 2
  • Follow the INICC Multidimensional Approach, which has demonstrated significant reductions in limited-resource settings 2

Important Context

The 2011 CDC guidelines remain foundational, but the 2024 ISID update incorporates a decade of additional evidence and addresses implementation challenges across diverse healthcare settings. 1 The guideline acknowledges that CLABSI measurement methodology remains imperfect, with significant underreporting of complications occurring outside monitored venues. 1 Despite this limitation, standardized surveillance using the ISID framework enables meaningful quality improvement when applied consistently. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Prevention and Treatment of Central Line-Associated Bloodstream Infections (CLABSIs)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

CLABSI Attribution in Boarding Situations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What are the guidelines for managing and preventing Central Line-Associated Bloodstream Infections (CLABSIs)?
What are the guidelines for preventing Central Line-Associated Bloodstream Infections (CLABSI)?
What is the recommended approach for diagnosing and treating a suspected Central Line-Associated Bloodstream Infection (CLABSI) in an adult or elderly patient with a central line in place?
What are the prevention and management strategies for Central Line-Associated Bloodstream Infections (CLABSI)?
What strategies can be implemented to reduce Central Line-Associated Bloodstream Infections (CLABSI) in a boarding unit?
What is the best method to measure serum vitamin D (25(OH)D) levels in adults, particularly those at risk for deficiency?
What is the management for a patient with gout and hyperuricemia, with normal creatinine (Cr) and urea levels?
What is the indication for using 3% (normal saline) in patients with severe acute symptomatic hyponatremia, particularly in elderly individuals or those with underlying medical conditions such as heart failure, liver disease, or Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH)?
What is the best treatment for a female patient with severe iron deficiency anemia and heavy menstrual bleeding?
What are the guidelines for safe telehealth prescribing of Glucagon-like peptide-1 inhibitors (GLPIs) for weight loss in patients with a Body Mass Index (BMI) of 30 or higher, or 27 or higher with at least one weight-related condition, considering their medical history, current medications, and potential risks?
How do we manage hyponatremia in a patient with cirrhosis (liver disease) and ascites (fluid accumulation in the abdomen)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.